The Middle East and North Africa (MENA) region now carries one of the highest burdens of diabetes and obesity globally, according to data from the International Diabetes Federation (IDF) and the World Health Organization (WHO). Countries including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates consistently rank among nations with the highest prevalence rates of both conditions worldwide.
A Rapidly Shifting Health Landscape
Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels, resulting from either insufficient insulin production, impaired insulin function, or both. Type 2 diabetes — the most prevalent form — is closely associated with excess body weight, physical inactivity, and genetic predisposition. Obesity, defined clinically by a body mass index (BMI) exceeding 30, is itself recognized as a complex, multifactorial disease influenced by genetic, environmental, behavioral, and socioeconomic factors.
Across the Gulf Cooperation Council (GCC) states, the transition from traditionally active, agrarian lifestyles to urban, technology-dependent patterns over the span of a few decades has been cited by public health researchers as a significant structural factor in rising prevalence rates. High per capita income levels in Gulf states have also been associated with increased consumption of processed and calorie-dense foods.
Health System Responses
Several governments in the region have established dedicated national diabetes programs and non-communicable disease (NCD) strategies. Saudi Arabia's Vision 2030 framework includes specific health outcome targets related to chronic disease reduction. The UAE has invested in large-scale national screening infrastructure. Jordan and Egypt, facing different economic contexts, have focused on strengthening primary healthcare capacity to manage the growing patient load.
Among the medical procedures used in managing diabetes across the region are insulin therapy, oral hypoglycemic medications, continuous glucose monitoring systems, and, in cases of severe obesity, bariatric surgical interventions. Endocrinology and metabolic medicine departments have expanded in major hospitals across Gulf states in response to clinical demand.
A Demographic Dimension
Public health researchers have highlighted that younger populations are increasingly affected, with Type 2 diabetes — historically associated with older adults — now being diagnosed at earlier ages across the region. This demographic shift carries long-term implications for healthcare system capacity and workforce productivity.
Open Questions
Whether national health strategies will prove sufficient to reverse current trends, and how lower-income MENA countries with constrained health budgets will manage escalating chronic disease burdens, remain subjects of ongoing policy debate and academic research.
Sources: International Diabetes Federation (IDF) Diabetes Atlas; World Health Organization (WHO) MENA Regional Office; Gulf Cooperation Council Health Ministers Council; Saudi Vision 2030 Health Sector Transformation Program; WHO Global Health Observatory Data.
This article was compiled with the support of advanced research technology, based on multiple verified sources, and reviewed by our editorial team. The information provided is for general informational purposes only and does not constitute medical, therapeutic or health advice. This article is not a substitute for professional diagnosis, consultation or treatment by qualified healthcare professionals.
